Shares in Gritstone bio, a US biotech that claims to be developing the world’s most potent vaccines, closed Tuesday’s trading nearly 49% lower. 3 April 2024
Veeda Clinical Research Limited.a full-service contract research organization (CRO) with a proven record of drug development success.announced that it has acqui 27 March 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.